Portolés Olga, Sorlí José Vicente, Francés Francesc, Coltell Oscar, González Jose I, Sáiz Carmen, Corella Dolores
Genetic and Molecular Epidemiology Unit. Department of Preventive Medicine and Public Health. School of Medicine, University of Valencia, Avda. Blasco Ibañez 15, 46010 Valencia, Spain.
Eur J Epidemiol. 2006;21(8):605-12. doi: 10.1007/s10654-006-9045-6. Epub 2006 Sep 20.
There are no good genetic markers for incorporating the study of genetic susceptibility to obesity in epidemiological studies. In animal models, the leptin (LEP) and the leptin receptor (LEPR) genes have been shown to be very important in obesity because leptin functions as a negative feedback signal in regulating body-weight through reducing food intake and stimulating energy expenditure. In humans, several polymorphisms in these genes have been described. However, their association with obesity is still very controversial because there are no good case-control studies designed to specifically test this association. Our objective has been to conduct a population-based case-control study to estimate the risk of obesity arising from the -2548G > A and Q223R polymorphisms in the LEP and LEPR genes, respectively. 303 obese cases (101 men and 202 women) and 606 controls (202 men and 404 women) were selected from a Spanish Mediterranean population. Genetic, clinical and life-style characteristics were analyzed. No association was found between the -2548G > A polymorphism and obesity. However, the Q223R variant was significantly associated with obesity in a recessive model, the RR genotype being more prevalent in controls than in obese subjects. The inverse association between the Q223R polymorphism and obesity (OR = 0.62; 95% CI: 0.39-0.99) remained significant even after additional adjustment for education, tobacco smoking, alcohol, physical activity, origin of the obese patient, and the -2548G > A polymorphism in the LEP gene (OR = 0.54; 95% CI: 0.32-0.89). In conclusion, the -2548G > A polymorphism is not a relevant obesity marker in this Mediterranean population, although Q223R does seen to be so.
在流行病学研究中,没有很好的基因标记可用于纳入肥胖遗传易感性的研究。在动物模型中,瘦素(LEP)基因和瘦素受体(LEPR)基因在肥胖中已被证明非常重要,因为瘦素通过减少食物摄入和刺激能量消耗,作为调节体重的负反馈信号发挥作用。在人类中,已描述了这些基因中的几种多态性。然而,它们与肥胖的关联仍然存在很大争议,因为没有专门设计用于测试这种关联的良好病例对照研究。我们的目标是进行一项基于人群的病例对照研究,以估计分别由LEP和LEPR基因中的-2548G>A和Q223R多态性引起肥胖的风险。从西班牙地中海人群中选取了303例肥胖病例(101名男性和202名女性)和606名对照(202名男性和404名女性)。对遗传、临床和生活方式特征进行了分析。未发现-2548G>A多态性与肥胖之间存在关联。然而,Q223R变体在隐性模型中与肥胖显著相关,RR基因型在对照中比在肥胖受试者中更普遍。即使在对教育、吸烟、饮酒、体育活动、肥胖患者的出身以及LEP基因中的-2548G>A多态性进行额外调整后,Q223R多态性与肥胖之间的反向关联(OR = 0.62;95%CI:0.39-0.99)仍然显著(OR = 0.54;95%CI:0.32-0.89)。总之,在这个地中海人群中,-2548G>A多态性不是一个相关的肥胖标记,尽管Q223R似乎是。